The rationale for a new triphasic contraceptive
- 1 January 1980
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Plasma Lipids and High Density Lipoproteins during Oral Contraception with Different Combinations of Ethinyl Estradiol and LevonorgestrelHormone and Metabolic Research, 1979
- LOWERING OF H.D.L. CHOLESTEROL BY ORAL CONTRACEPTIVESThe Lancet, 1978
- Serum High-Density-Lipoprotein Cholesterol in Women Using Oral Contraceptives, Estrogens and ProgestinsNew England Journal of Medicine, 1978
- REDUCED HIGH-DENSITY LIPOPROTEIN IN WOMEN AGED 40-41 USING ORAL CONTRACEPTIVESThe Lancet, 1978
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970
- Combined oral contraceptives. A statement by the committee on safety of drugs.BMJ, 1970
- Oestrogens and thromboembolism.BMJ, 1970